MRAP
Basic information
Region (hg38): 21:32291813-32314784
Previous symbols: [ "C21orf61" ]
Links
Phenotypes
GenCC
Source:
- familial glucocorticoid deficiency (Supportive), mode of inheritance: AR
- glucocorticoid deficiency 2 (Strong), mode of inheritance: AR
- glucocorticoid deficiency 2 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Glucocorticoid deficiency 2 | AR | Endocrine | Cortisol treatment can be effective to pevent manifestations such as hypoglycemia or severe sequelae of infectious episodes in infancy/childhood | Endocrine | 15654338; 16868047; 20427498; 21951701 |
ClinVar
This is a list of variants' phenotypes submitted to
- Glucocorticoid deficiency 2 (3 variants)
- Glucocorticoid deficiency 1 (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MRAP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 8 | |||||
missense | 15 | 22 | ||||
nonsense | 0 | |||||
start loss | 2 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 14 | |||||
Total | 4 | 0 | 29 | 9 | 8 |
Highest pathogenic variant AF is 0.0000920
Variants in MRAP
This is a list of pathogenic ClinVar variants found in the MRAP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-32291843-G-A | Glucocorticoid deficiency 2 | Uncertain significance (Jan 13, 2018) | ||
21-32291844-C-T | Glucocorticoid deficiency 2 | Uncertain significance (Jan 13, 2018) | ||
21-32291974-C-T | Glucocorticoid deficiency 2 | Uncertain significance (May 12, 2023) | ||
21-32293013-A-G | Glucocorticoid deficiency 2 | Benign (Jan 12, 2018) | ||
21-32293052-C-T | Glucocorticoid deficiency 2 | Likely benign (Jan 12, 2018) | ||
21-32293076-C-T | Glucocorticoid deficiency 2 | Likely benign (Jan 13, 2018) | ||
21-32293102-AAG-A | Glucocorticoid Deficiency | Uncertain significance (Jun 14, 2016) | ||
21-32293123-G-C | Glucocorticoid deficiency 2 | Benign (Jan 13, 2018) | ||
21-32298972-A-G | Glucocorticoid deficiency 1 | Pathogenic (Sep 30, 2017) | ||
21-32298974-G-A | Glucocorticoid deficiency 2 • Glucocorticoid deficiency 1 | Pathogenic (Sep 30, 2017) | ||
21-32298982-G-A | Inborn genetic diseases | Uncertain significance (Apr 11, 2023) | ||
21-32298987-AACGCCTC-A | Glucocorticoid deficiency 2 | Pathogenic (Oct 01, 2006) | ||
21-32298989-C-A | Inborn genetic diseases | Uncertain significance (Jun 05, 2024) | ||
21-32298990-G-A | Inborn genetic diseases | Uncertain significance (Mar 18, 2024) | ||
21-32299006-A-G | Inborn genetic diseases | Uncertain significance (Jun 07, 2024) | ||
21-32299024-T-C | Inborn genetic diseases | Uncertain significance (Feb 14, 2024) | ||
21-32299047-G-A | Inborn genetic diseases | Uncertain significance (Jan 15, 2021) | ||
21-32299052-C-T | MRAP-related disorder | Likely benign (Jul 10, 2024) | ||
21-32299077-CG-C | Glucocorticoid deficiency 1 • Glucocorticoid deficiency 2 | Pathogenic (May 22, 2022) | ||
21-32299078-G-A | Glucocorticoid deficiency 2 | Pathogenic (Feb 01, 2005) | ||
21-32299078-G-C | Glucocorticoid deficiency 2 | Pathogenic (May 12, 2023) | ||
21-32299078-G-T | Glucocorticoid deficiency 2 | Pathogenic (Feb 01, 2005) | ||
21-32299080-A-AT | Glucocorticoid deficiency 2 | Pathogenic (Feb 01, 2005) | ||
21-32299092-G-C | Glucocorticoid deficiency 2 | Uncertain significance (Jan 12, 2018) | ||
21-32306635-C-T | Glucocorticoid deficiency 2 | Uncertain significance (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MRAP | protein_coding | protein_coding | ENST00000399784 | 3 | 22972 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00208 | 0.525 | 125700 | 0 | 48 | 125748 | 0.000191 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0747 | 103 | 101 | 1.02 | 0.00000580 | 1113 |
Missense in Polyphen | 31 | 25.77 | 1.203 | 314 | ||
Synonymous | -1.16 | 58 | 47.8 | 1.21 | 0.00000334 | 350 |
Loss of Function | 0.176 | 4 | 4.40 | 0.909 | 2.87e-7 | 44 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000149 | 0.000148 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00106 | 0.00106 |
European (Non-Finnish) | 0.000132 | 0.000132 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000982 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Modulator of melanocortin receptors (MC1R, MC2R, MC3R, MC4R and MC5R). Acts by increasing ligand-sensitivity of melanocortin receptors and enhancing generation of cAMP by the receptors. Required both for MC2R trafficking to the cell surface of adrenal cells and for signaling in response to corticotropin (ACTH). May be involved in the intracellular trafficking pathways in adipocyte cells. {ECO:0000269|PubMed:15654338, ECO:0000269|PubMed:19329486, ECO:0000269|PubMed:20371771}.;
- Pathway
- Cortisol synthesis and secretion - Homo sapiens (human);Cushing,s syndrome - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.357
Intolerance Scores
- loftool
- 0.348
- rvis_EVS
- 0.37
- rvis_percentile_EVS
- 75.29
Haploinsufficiency Scores
- pHI
- 0.164
- hipred
- N
- hipred_score
- 0.146
- ghis
- 0.437
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.313
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mrap
- Phenotype
Gene ontology
- Biological process
- protein localization to plasma membrane;positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway;negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway;negative regulation of protein localization to plasma membrane
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;plasma membrane;integral component of membrane
- Molecular function
- protein binding;corticotropin hormone receptor binding;type 3 melanocortin receptor binding;type 4 melanocortin receptor binding;type 5 melanocortin receptor binding;identical protein binding;type 1 melanocortin receptor binding